Latest in Why the investor craze for Ozempic and rival weight loss drugs may resume next year
Sort by
1,524 items
-
Why Mets' Clay Holmes gamble may pay off: Three reasons to think ex-closer could make it as a starter
The Mets reportedly plan to try Holmes in the rotation after agreeing to a three-year, $38 million contractCBS Sports - Dec. 8 -
Fentanyl may enter the US from Mexico, but the drug of choice there is different
Use of crystal meth is soaring among workers, partiers and the young and threatening a public health crisis. All night, Daniela stares at screens in the warehouse where she works as a security ...The Guardian - Dec. 8 -
If McGregor fights it will be sometime next year - White
UFC president Dana White says if Conor McGregor fights again in the promotion it "will be sometime next year".Yahoo Sports - Dec. 8 -
SMU's case for College Football Playoff: Why Mustangs deserve spot in bracket despite loss in ACC title game
A last-second loss in a conference title game shouldn't push the No. 8 Mustangs out of the College Football PlayoffCBS Sports - Dec. 8 -
Ernst and Hegseth to resume meetings next week
Sen. Joni Ernst (R-Iowa) said she will meet with Secretary of Defense nominee Pete Hegseth again next week as he continues to pitch himself to lawmakers on Capitol Hill. “Pete Hegseth and I will ...The Hill - Dec. 7 -
Why TikTok Faces a U.S. Ban, and What’s Next?
The short-form video app lost a challenge to a law that will ban TikTok in the United States if its owner, ByteDance, does not sell to a non-Chinese company. It has pledged to appeal to the Supreme ...The New York Times - Dec. 6 -
The stock market’s ‘fear gauge’ is trading at lows. Why retail investors should take note.
The Cboe Volatility Index hasn’t been this low in months.MarketWatch - Dec. 6 -
Google’s CEO Says Search Will Change ‘Profoundly’ Next Year
Google is one of the pillars of the internet, so it’s time to pay attention when Sundar Pichai predicts an upheaval.Inc. - Dec. 6 -
Why Your Company May Buy OpenAI’s New $200 a Month ChatGPT Pro Subscription
Access to the best features of a leading product often comes at a premium, which the market leading AI system has set at 10 times the price of a regular subscription.Inc. - Dec. 6 -
Indonesia agrees to repatriate Filipino woman who spent years on death row over drug trafficking
Indonesia and the Philippines signed a deal on Friday to repatriate a Filipino death-row drug convict, as the new administration of President Prabowo Subianto seeks to shore up diplomatic ties with ...ABC News - Dec. 6 -
Why you shouldn't wait for the Geminid meteor shower peak this year
The Geminid meteor shower this year is set to peak at almost the same time as December's full moon, which could make for challenging viewing conditions.CBS News - Dec. 6 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
The Allure of ‘Microdosing’ Ozempic
Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it work?The New York Times - Dec. 5 -
Why did France's government collapse and what happens next?
Emmanuel Macron appears to have few good options after Michel Barnier’s government became the first to fall from a no-confidence vote in more than 60 years. The French prime minister, Michel ...The Guardian - Dec. 5 -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - Dec. 5 -
Legendary drug lord released after serving 25 years in U.S. prison
Fabio Ochoa Vásquez and his brothers amassed a fortune when cocaine started flooding the U.S. in the late 1970s and early 1980s.CBS News - Dec. 5 -
World’s biggest hedge fund flags the ‘holy grail’ that may shield investors if U.S. stock rally crumbles
Karen Karniol-Tambour, co-chief investment officer at Bridgewater Associates, says valuations are much higher for U.S. stocks than they were when the bull run began.MarketWatch - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5 -
Legendary Medellin cartel drug lord released from US prison after serving 25 years
One of Colombia’s legendary drug lords and a key operator of the Medellin cocaine cartel has been released from a federal prison in the U.S. and is expected to be deported back homeABC News - Dec. 4 -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
Head of Democratic Caucus says thin House margins make attendance vital next year
The head of the House Democratic Caucus is sending an early message to his troops heading into the 119th Congress: Attendance will be crucial given the razor-tight margins in the lower chamber. ...The Hill - Dec. 4 -
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...The Hill - Dec. 4 -
Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive weight loss drug race.CNBC - Dec. 4 -
Why Rules On Data Scammers and Credit Card Fees May Be the Consumer Financial Protection Bureau’s Swansong
The CFPB is meant to act in the best interest of the American consumer, but powerful corporate opposition and the ire of Elon Musk may mean a dicey future for the agency.Inc. - Dec. 4 -
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy
Zepbound helped patients lose more weight than a major rival in a head-to-head trial.MarketWatch - Dec. 4 -
Why the Chicago Bears Should Hire Bill Belichick as Their Next Coach
Yes, Belichick comes with a ton of question marks. But he’s also the greatest N.F.L. coach of all time, a columnist for The Athletic writes.The New York Times - Dec. 4 -
Investors' crypto donations to charity skyrocket. Why it can be 'hugely beneficial,' expert says
There's soaring interest in donating crypto to charity, according to Fidelity Charitable. Here's how those donations can pay off at tax time.CNBC - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4 -
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.CNBC - Dec. 4 -
BoE governor expects four UK rate cuts next year as inflation eases
Andrew Bailey welcomes better than expected fall in price growth in FT interviewFinancial Times - Dec. 4 -
Music sector workers to lose nearly a quarter of income to AI in next four years, global study finds
AI boom will enrich giant tech companies but creators’ rights and income will be drastically reduced unless policymakers intervene, report warns. Follow our Australia news live blog for latest ...The Guardian - Dec. 4 -
Trump’s election win fueled crypto XRP’s rally to a new high. Here’s why its gains may last.
XRP, the world’s third-largest cryptocurrency by market capitalization, hit a record high at $2.90 on Tuesday before pulling back — with its rally fueled by optimism around a more friendly ...MarketWatch - Dec. 3 -
Boeing’s volatile bonds could outshine the defense sector next year
Boeing Co. was named a “best idea” by the U.S. investment-grade team at CreditSights on Tuesday, on expectations the troubled aerospace company can stabilize its ratings and provide a path to ...MarketWatch - Dec. 3 -
Talks on a new NHL CBA are set to start early next year. Here's why there is optimism
Talks on a new collective bargaining agreement between the NHL and NHL Players' Association are set to begin in early 2025ABC News - Dec. 3 -
Experts create controllable gastric balloon to aid weight loss
Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...The Guardian - Dec. 3 -
AT&T sees earnings growth over next 3 years; eyes more than $40B in anticipated shareholder returns
AT&T anticipates earnings growth over the next three years thanks to the momentum of 5G and fiber servicesABC News - Dec. 3 -
Next Game Pass Release Is A Crash Bandicoot Kart Racer, And That May Not Be All
The calendar has flipped over to December, and while Microsoft isn't ready to reveal all the games headed to Game Pass this month, the company has announced one: Crash Team Racing Nitro-Fueled. The ...GameSpot - Dec. 3 -
Why America’s economy is soaring ahead of its rivals
The country’s outperformance is rooted in long-term productivity growth that is the envy of the developed world. Could Trump’s policies endanger its lead?Financial Times - Dec. 3 -
U.S. 10-year Treasury yield is little changed as investors look to key labor data this week
Investors awaited economic data, expected to be published through the week, including labor and manufacturing insights.CNBC - Dec. 2 -
Ravens’ loss to Eagles highlights potential hole in their playoff hopes. How concerned should they be — and what comes next?
Can Baltimore trust kicker Justin Tucker the rest of the season? And if there's any doubt, should they change how they use him?Yahoo Sports - Dec. 2